Quarterly Transactions Made in Allogene Therapeutics, Inc. (ALLO)
This table provides information about the institutional ownership of Allogene Therapeutics, Inc. (ALLO). The information is specifically focused on institutions that hold shares of Allogene Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 4,896,162 | 8,022,009 | 12,918,171 | 1,764,899 | 3,150,930 | 4,915,829 | 8,002,342 | |
| Q4 2021 | 10,133,950 | 23,037,639 | 33,171,589 | 9,272,622 | 6,631,797 | 15,904,419 | 17,267,170 | |
| Q1 2022 | 14,454,582 | 2,783,407 | 17,237,989 | 3,451,734 | 8,142,262 | 11,593,996 | 5,643,993 | |
| Q2 2022 | 17,205,458 | 6,397,448 | 23,602,906 | 11,760,904 | 2,482,826 | 14,243,730 | 9,359,176 | |
| Q3 2022 | 10,053,977 | 3,504,618 | 13,558,595 | 6,547,456 | 0 | 6,547,456 | 7,011,139 | |
| Q4 2022 | 12,231,933 | 3,113,134 | 15,345,067 | 6,352,290 | 418 | 6,352,708 | 8,992,359 | |
| Q1 2023 | 10,600,059 | 5,618,733 | 16,218,792 | 7,587,057 | 0 | 7,587,057 | 8,631,735 | |
| Q2 2023 | 31,546,698 | 3,550,806 | 35,097,504 | 7,769,686 | 923,009 | 8,692,695 | 26,404,809 | |
| Q3 2023 | 7,769,387 | 949,076 | 8,718,463 | 9,341,860 | 923,009 | 10,264,869 | -1,546,406 | |
| Q4 2023 | 8,363,147 | 4,978,090 | 13,341,237 | 15,050,769 | 0 | 15,050,769 | -1,709,532 | |
| Q1 2024 | 14,109,265 | 9,543,833 | 23,653,098 | 9,896,803 | 0 | 9,896,803 | 13,756,295 | |
| Q2 2024 | 26,077,497 | 15,141,856 | 41,219,353 | 5,628,148 | 0 | 5,628,148 | 35,591,205 | |
| Q3 2024 | 7,454,269 | 6,903,046 | 14,357,315 | 7,305,266 | 169,348 | 7,474,614 | 6,882,701 | |